Form 8-K - Current report:
SEC Accession No. 0000875320-26-000256
Filing Date
2026-08-03
Accepted
2026-08-03 16:09:43
Documents
12
Period of Report
2026-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vrtx-20260803.htm   iXBRL 8-K 24816
2 EX-99.1 ex-991_q22026.htm EX-99.1 254111
  Complete submission text file 0000875320-26-000256.txt   421175

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20260803.xsd EX-101.SCH 1870
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20260803_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20260803_pre.xml EX-101.PRE 12595
16 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20260803_htm.xml XML 2720
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 261232923
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)